Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in AKBA — Akebia Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$292,845
+$29,459 QoQ
Shares Held
256,883
+35.6% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 170 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. AKBA ranks #35 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 5,851,737 $420,505,812
2 VTRS
Viatris Inc
 7,891,271 $125,313,379
3 UTHR
UNITED THERAPEUTICS Corp
 195,269 $105,802,598
4 TEVA
Teva Pharmaceutical Industries Ltd
 3,037,225 $102,901,179
5 NBIX
Neurocrine Biosciences Inc
 334,650 $56,401,907
6 LNTH
Lantheus Holdings, Inc.
 248,743 $27,595,547
7 ANIP
Ani Pharmaceuticals Inc
 323,443 $26,774,610
8 KNSA
Kiniksa Pharmaceuticals International, plc
 387,606 $24,787,402

All Filings in AKBA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $292,845 256,883
2026-03-31 $263,386 189,487
2025-12-31 $265,093 164,655
2025-09-30 $427,386 156,552
2025-06-30 $479,362 131,693
2025-03-31 $309,344 161,117
2024-12-31 $343,991 181,048
2024-09-30 $145,708 110,385
2022-03-31 $77,681 108,193
2021-12-31 $269,908 119,429
2021-09-30 $331,731 115,185
2021-06-30 $415,872 109,729
2021-03-31 $376,471 111,218
2020-12-31 $336,343 120,123
2020-09-30 $1,107,224 441,126
2020-06-30 $3,747,373 275,948
2020-03-31 $1,795,717 236,902